Literature DB >> 3001282

Oxytocin causes endothelium-dependent relaxations of canine basilar arteries by activating V1-vasopressinergic receptors.

Z S Katusic, J T Shepherd, P M Vanhoutte.   

Abstract

Experiments were designed to study the effects of oxytocin on canine basilar and femoral arteries and to compare these with the effects of vasopressin. Rings of the arteries were suspended in physiological salt solution for isometric tension recording. Oxytocin and vasopressin caused endothelium-dependent relaxation of basilar arteries contracted with prostaglandin F2 alpha. Vasopressin was more potent than oxytocin. In the femoral artery, the two hormones caused endothelium-independent contractions with the same order of potency. The relaxations of the basilar artery occurred at lower concentrations of each substance than the contractions of the femoral artery. The relaxations in response to both agonists were inhibited competitively, and the contractions noncompetitively, by the V1-vasopressinergic antagonist d(CH2)5Tyr(Me)AVP; the antagonist did not affect endothelium-dependent relaxations in response to bradykinin. Thus, both oxytocin and vasopressin cause endothelium-dependent relaxation of the basilar artery by activating V1-vasopressinergic receptors; the contractions of femoral arteries that they cause also may be mediated in part by V1-vasopressinergic receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3001282

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Oxytocin-induced endothelial nitric oxide dependent vasorelaxation and ERK1/2-mediated vasoconstriction in the rat aorta.

Authors:  Qian Xu; Kunping Zhuo; Xiaotian Zhang; Yaoxia Zhang; Jiaojiao Xue; Ming-Sheng Zhou
Journal:  Korean J Physiol Pharmacol       Date:  2022-07-01       Impact factor: 1.718

2.  HN-10200 causes endothelium-independent relaxations in isolated canine arteries.

Authors:  F Cosentino; A Schirger; Z S Katusić
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

3.  Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels.

Authors:  T Tagawa; T Imaizumi; T Endo; M Shiramoto; Y Hirooka; S Ando; A Takeshita
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

4.  Vasopressin and oxytocin in control of the cardiovascular system.

Authors:  Nina Japundžić-Žigon
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

Review 5.  The Paraventricular Nucleus of the Hypothalamus in Control of Blood Pressure and Blood Pressure Variability.

Authors:  Bojana Savić; David Murphy; Nina Japundžić-Žigon
Journal:  Front Physiol       Date:  2022-03-16       Impact factor: 4.566

6.  Overexpression of oxytocin receptors in the hypothalamic PVN increases baroreceptor reflex sensitivity and buffers BP variability in conscious rats.

Authors:  Maja Lozić; Michael Greenwood; Olivera Šarenac; Andrew Martin; Charles Hindmarch; Tatjana Tasić; Julian Paton; David Murphy; Nina Japundžić-Žigon
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

Review 7.  Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review.

Authors:  Nina Japundžić-Žigon; Maja Lozić; Olivera Šarenac; David Murphy
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.